Cost to bring large cap biopharmaceutical assets to market 2010-2019

This statistic shows the cost to bring biopharmaceutical asset to market in 2010, 2016, 2017, 2018, and 2019. According to the data, in 2019, the cost to bring an asset to market was almost two billion U.S. dollars.

Average cost to bring a pharmaceutical asset to market among large cap biopharma companies between 2010 and 2019

Cost in billion U.S. dollars
--
--
--
--
--
Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

2019

Region

Worldwide

Survey time period

2010, 2016, 2017, 2018, and 2019

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Biotech industry"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.